Vertex Pharma (VRTX) volatility elevated at 58 into PDUFA

Vertex Pharma (Nasdaq: VRTX) PDUFA date for telaprevir (hepatitis C virus treatment) is expected on May 23. May and July put option implied volatility is at 58; above its six-month average of 42 according to Track Data, suggesting larger price movement.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
• CrowdStrike Holdings Inc. (CRWD) call put ratio 1 call to 1 put into quarter results
• NVIDIA (NVDA) 10K contracts of September 125 puts trade